{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:37:08Z","timestamp":1784903828427,"version":"3.55.0"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T00:00:00Z","timestamp":1565740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009382","name":"Solve ME\/CFS Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014224","name":"Open Medicine Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001981","name":"ME Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001981","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004200","name":"Stiftelsen Olle Engkvist Byggm\u00e4stare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004200","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01946","type":"journal-article","created":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T10:35:06Z","timestamp":1565778906000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome Patients"],"prefix":"10.3389","volume":"10","author":[{"given":"Jonas","family":"Blomberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Rizwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"B\u00f6hlin-Wiener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Elfaitouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Julin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Zachrisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Ros\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl-Gerhard","family":"Gottfries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fimmu.2018.00229","article-title":"Infection elicited autoimmunity and myalgic encephalomyelitis\/chronic fatigue syndrome: an explanatory model","volume":"9","author":"Blomberg","year":"2018","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/bmj.38933.585764.AE","article-title":"Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study","volume":"333","author":"Hickie","year":"2006","journal-title":"BMJ"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e0155884","DOI":"10.1371\/journal.pone.0155884","article-title":"Fatigue following acute Q-fever: a systematic literature review","volume":"11","author":"Morroy","year":"2016","journal-title":"PLoS ONE"},{"key":"B4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12876-015-0296-0","article-title":"The relationship between irritable bowel syndrome, functional dyspepsia, chronic fatigue and overactive bladder syndrome: a controlled study 6 years after acute gastrointestinal infection","volume":"15","author":"Persson","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1136\/gutjnl-2011-300220","article-title":"Irritable bowel syndrome and chronic fatigue 3 years after acute giardiasis: historic cohort study","volume":"61","author":"Wensaas","year":"2012","journal-title":"Gut"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcv.2006.10.011","article-title":"Post-infectious fatigue syndrome in dengue infection","volume":"38","author":"Seet","year":"2007","journal-title":"J Clin Virol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12887-016-0596-8","article-title":"Tracking post-infectious fatigue in clinic using routine Lab tests","volume":"16","author":"Harvey","year":"2016","journal-title":"BMC Pediatr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/MOP.0b013e32835c1108","article-title":"Chronic fatigue syndrome following infections in adolescents","volume":"25","author":"Katz","year":"2013","journal-title":"Curr Opin Pediatr"},{"key":"B9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1542\/peds.2008-1879","article-title":"Chronic fatigue syndrome after infectious mononucleosis in adolescents","volume":"124","author":"Katz","year":"2009","journal-title":"Pediatrics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1136\/jcp.2009.072561","article-title":"Microbial infections in eight genomic subtypes of chronic fatigue syndrome\/myalgic encephalomyelitis","volume":"63","author":"Zhang","year":"2010","journal-title":"J Clin Pathol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.7326\/0003-4819-102-1-7","article-title":"Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection","volume":"102","author":"Straus","year":"1985","journal-title":"Ann Intern Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1001\/archinte.148.9.1957","article-title":"Antibodies to Epstein-Barr virus-specific DNase and DNA polymerase in the chronic fatigue syndrome","volume":"148","author":"Jones","year":"1988","journal-title":"Arch Intern Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1001\/jama.257.17.2303","article-title":"Frequency of 'chronic active Epstein-Barr virus infection' in a general medical practice","volume":"257","author":"Buchwald","year":"1987","journal-title":"JAMA"},{"key":"B14","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1001\/jama.260.7.971","article-title":"Chronic fatigue syndrome and the diagnostic utility of antibody to Epstein-Barr virus early antigen","volume":"260","author":"Hellinger","year":"1988","journal-title":"JAMA"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1001\/jama.257.17.2297","article-title":"A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause?","volume":"257","author":"Holmes","year":"1987","journal-title":"JAMA"},{"key":"B16","first-page":"101","article-title":"IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome","volume":"18","author":"Lerner","year":"2004","journal-title":"In vivo"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e47891","DOI":"10.1371\/journal.pone.0047891","article-title":"Antibody to Epstein-Barr virus deoxyuridine triphosphate nucleotidohydrolase and deoxyribonucleotide polymerase in a chronic fatigue syndrome subset","volume":"7","author":"Lerner","year":"2012","journal-title":"PLoS ONE"},{"key":"B18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1159\/000150450","article-title":"Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome","volume":"38","author":"Sairenji","year":"1995","journal-title":"Intervirology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2169\/internalmedicine.31.313","article-title":"Studies on the relationship between chronic fatigue syndrome and Epstein-Barr virus in Japan","volume":"31","author":"Kawai","year":"1992","journal-title":"Intern Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1097\/00007611-198411000-00007","article-title":"Chronic mononucleosis syndrome","volume":"77","author":"DuBois","year":"1984","journal-title":"South Med J"},{"key":"B21","first-page":"71","article-title":"The 'chronic mononucleosis' syndromes","volume":"22","author":"Komaroff","year":"1987","journal-title":"Hosp Pract."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1002\/jmv.21873","article-title":"Serological and virological investigation of the role of the herpesviruses EBV, CMV, and HHV-6 in post-infective fatigue syndrome","volume":"82","author":"Cameron","year":"2010","journal-title":"J Med Virol"},{"key":"B23","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1128\/CDLI.6.2.216-223.1999","article-title":"Human herpesviruses in chronic fatigue syndrome","volume":"6","author":"Wallace","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"B24","first-page":"939","article-title":"Sleep, Epstein-Barr virus infection, musculoskeletal pain, and depressive symptoms in chronic fatigue syndrome","volume":"19","author":"Whelton","year":"1992","journal-title":"J Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12875-016-0527-7","article-title":"Comorbidities treated in primary care in children with chronic fatigue syndrome \/ myalgic encephalomyelitis: a nationwide registry linkage study from Norway","volume":"17","author":"Bakken","year":"2016","journal-title":"BMC Fam Pract"},{"key":"B26","doi-asserted-by":"publisher","first-page":"205085","DOI":"10.1155\/2012\/205085","article-title":"Association of active human herpesvirus-6,\u22127 and parvovirus b19 infection with clinical outcomes in patients with myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"2012","author":"Chapenko","year":"2012","journal-title":"Adv Virol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S1386-6532(99)00079-7","article-title":"Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients","volume":"16","author":"Ablashi","year":"2000","journal-title":"J Clin Virol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1002\/jmv.24810","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome and gulf war illness patients exhibit increased humoral responses to the herpesviruses-encoded dUTPase: implications in disease pathophysiology","volume":"89","author":"Halpin","year":"2017","journal-title":"J Med Virol"},{"key":"B29","first-page":"46","article-title":"Chronic fatigue syndrome and herpesviruses: the fading evidence","volume":"7","author":"Soto","year":"2000","journal-title":"Herpes"},{"key":"B30","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41588-018-0102-3","article-title":"Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity","volume":"50","author":"Harley","year":"2018","journal-title":"Nat Genet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1136\/jcp.2006.042754","article-title":"Definitions and aetiology of myalgic encephalomyelitis: how the Canadian consensus clinical definition of myalgic encephalomyelitis works","volume":"60","author":"Carruthers","year":"2007","journal-title":"J Clin Pathol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1365-2796.2011.02428.x","article-title":"Myalgic encephalomyelitis: international consensus criteria","volume":"270","author":"Carruthers","year":"2011","journal-title":"J Intern Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0022-3999(01)00315-4","article-title":"A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale)","volume":"52","author":"Zachrisson","year":"2002","journal-title":"J Psychosom Res"},{"key":"B34","unstructured":"The xMAP Cookbook2016"},{"key":"B35","doi-asserted-by":"publisher","first-page":"E22","DOI":"10.3390\/microarrays5030022","article-title":"Serology in the digital age: using long synthetic peptides created from nucleic acid sequences as antigens in microarrays","volume":"5","author":"Rizwan","year":"2016","journal-title":"Microarrays."},{"key":"B36","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jneuroim.2009.08.004","article-title":"Antibodies to specific EBNA-1 domains and HLA DRB1*1501 interact as risk factors for multiple sclerosis","volume":"215","author":"Sundstrom","year":"2009","journal-title":"J Neuroimmunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/jmv.10385","article-title":"Infectious mononucleosis patients temporarily recognize a unique, cross-reactive epitope of Epstein-Barr virus nuclear antigen-1","volume":"70","author":"McClain","year":"2003","journal-title":"J Med Virol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12879-015-1194-3","article-title":"Microsphere-based antibody assays for human parvovirus B19V, CMV and T. gondii","volume":"16","author":"Wang","year":"2016","journal-title":"BMC Infect Dis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fneur.2017.00040","article-title":"Decreased HHV-6 IgG in Alzheimer's Disease","volume":"8","author":"Westman","year":"2017","journal-title":"Front Neurol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1007\/s00467-014-2860-1","article-title":"Prevalence of herpesviruses at onset of idiopathic nephrotic syndrome","volume":"29","author":"Dossier","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1365-2362.2009.02131.x","article-title":"Relative seroprevalence of human herpes viruses in patients with chronic lymphocytic leukaemia","volume":"39","author":"Steininger","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"B42","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1046\/j.1469-0691.2000.00129.x","article-title":"Human herpesviruses-6,\u22127, and\u22128 in organ transplant recipients","volume":"6","author":"Singh","year":"2000","journal-title":"Clin Microbiol Infect"},{"key":"B43","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1046\/j.1423-0410.1998.7530193.x","article-title":"Comparison of seroprevalences of human herpesvirus-6 and\u22127 in healthy blood donors from nine countries","volume":"75","author":"Krueger","year":"1998","journal-title":"Vox Sang"},{"key":"B44","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/jmv.1890460410","article-title":"Synthetic peptides deduced from the amino acid sequence of Epstein-Barr virus nuclear antigen 6 (EBNA 6): antigenic properties, production of monoreactive reagents, and analysis of antibody responses in man","volume":"46","author":"Falk","year":"1995","journal-title":"J Med Virol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12979-017-0093-4","article-title":"Herpes virus seroepidemiology in the adult Swedish population","volume":"14","author":"Olsson","year":"2017","journal-title":"Immun Ageing"},{"key":"B46","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1128\/JVI.61.4.1125-1135.1987","article-title":"Antigenic cross-reactions among herpes simplex virus types 1 and 2, Epstein-Barr virus, and cytomegalovirus","volume":"61","author":"Balachandran","year":"1987","journal-title":"J Virol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5501\/wjv.v1.i1.31","article-title":"Serological diagnosis of Epstein-Barr virus infection: problems and solutions","volume":"1","author":"De Paschale","year":"2012","journal-title":"World J Virol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"953","DOI":"10.7326\/0003-4819-121-12-199412150-00009","article-title":"The chronic fatigue syndrome: a comprehensive approach to its definition and study. International chronic fatigue syndrome study group","volume":"121","author":"Fukuda","year":"1994","journal-title":"Ann Intern Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/(SICI)1096-9071(199609)50:1<25::AID-JMV6>3.0.CO;2-V","article-title":"Viral serologies in patients with chronic fatigue and chronic fatigue syndrome","volume":"50","author":"Buchwald","year":"1996","journal-title":"J Med Virol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/imm.12200","article-title":"Epstein-Barr virus antibodies mark systemic lupus erythematosus and scleroderma patients negative for anti-DNA","volume":"141","author":"Fattal","year":"2014","journal-title":"Immunology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1365-2567.2010.03245.x","article-title":"An antibody profile of systemic lupus erythematosus detected by antigen microarray","volume":"130","author":"Fattal","year":"2010","journal-title":"Immunology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/978-3-319-22834-1_10","article-title":"Epstein-Barr virus-specific humoral immune responses in health and disease","volume":"391","author":"Middeldorp","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/j.1468-1331.2010.03005.x","article-title":"Epstein-Barr virus neutralizing and early antigen antibodies in multiple sclerosis","volume":"17","author":"Lindsey","year":"2010","journal-title":"Eur J Neurol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/jmv.24904","article-title":"Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profile","volume":"90","author":"Chougule","year":"2018","journal-title":"J Med Virol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.virusres.2014.09.014","article-title":"Elevated antinuclear antibodies and altered anti-Epstein-Barr virus immune responses","volume":"195","author":"Cuomo","year":"2015","journal-title":"Virus Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1177\/1352458508092353","article-title":"EBNA-1 reactivity and HLA DRB1*1501 as statistically independent risk factors for multiple sclerosis: a case-control study","volume":"14","author":"Sundstrom","year":"2008","journal-title":"Mult Scler"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1212\/01.WNL.0000130496.51156.D7","article-title":"An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study","volume":"62","author":"Sundstrom","year":"2004","journal-title":"Neurology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jneuroim.2014.04.005","article-title":"Multiple sclerosis: the elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1","volume":"272","author":"Ruprecht","year":"2014","journal-title":"J Neuroimmunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e2010022","DOI":"10.4084\/mjhid.2010.022","article-title":"EBV chronic infections","volume":"2","author":"Eligio","year":"2010","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"B60","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/j.1365-2141.1995.tb05579.x","article-title":"Chronic active Epstein-Barr virus disease in a case of persistent polyclonal B-cell lymphocytosis","volume":"90","author":"Mitterer","year":"1995","journal-title":"Br J Haematol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1111\/j.1651-2227.1995.tb13547.x","article-title":"Chronic active Epstein-Barr virus infection in children in Japan","volume":"84","author":"Ishihara","year":"1995","journal-title":"Acta Paediatr"},{"key":"B62","first-page":"29","article-title":"Dual infections of the immune system in patients with chronic active Epstein-Barr virus infection mimicking chronic fatigue syndrome","volume":"17","author":"Purtilo","year":"1991","journal-title":"Can Dis Wkly Rep"},{"key":"B63","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/infdis\/156.1.26","article-title":"Selective lack of antibody to a component of EB nuclear antigen in patients with chronic active Epstein-Barr virus infection","volume":"156","author":"Miller","year":"1987","journal-title":"J Infect Dis"},{"key":"B64","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1073\/pnas.84.2.570","article-title":"Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection","volume":"84","author":"Henle","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1099\/vir.0.83686-0","article-title":"Antibodies against Epstein-Barr virus gp78 antigen: a novel marker for serological diagnosis of nasopharyngeal carcinoma detected by xMAP technology","volume":"89","author":"Gu","year":"2008","journal-title":"J Gen Virol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e0179124","DOI":"10.1371\/journal.pone.0179124","article-title":"Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray","volume":"12","author":"Loebel","year":"2017","journal-title":"PLoS ONE"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e00375","DOI":"10.1128\/JVI.00375-17","article-title":"Natural variation of Epstein-Barr virus genes, proteins, and primary MicroRNA","volume":"91","author":"Correia","year":"2017","journal-title":"J Virol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/pai.12030","article-title":"Herpesvirus infections and allergic sensitization in children of families with anthroposophic and non-anthroposophic lifestyle - the ALADDIN birth cohort","volume":"24","author":"Hesla","year":"2013","journal-title":"Pediatr Allergy Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jcv.2011.06.008","article-title":"Deciphering the clinical impact of acute human herpesvirus 6 (HHV-6) infections","volume":"52","author":"Agut","year":"2011","journal-title":"J Clin Virol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1002\/jmv.23685","article-title":"Persistent human herpesvirus-6 infection in patients with an inherited form of the virus","volume":"85","author":"Pantry","year":"2013","journal-title":"J Med Virol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1128\/CDLI.9.2.394-402.2002","article-title":"Elucidation of the cross-reactive immunoglobulin M response to human herpesviruses 6 and 7 on the basis of neutralizing antibodies","volume":"9","author":"Yoshida","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1086\/315115","article-title":"Reactivation of human herpesvirus 6 during pregnancy","volume":"180","author":"Dahl","year":"1999","journal-title":"J Infect Dis"},{"key":"B73","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S1386-6532(99)00070-0","article-title":"Seroprevalence of viral childhood infections in Eritrea","volume":"16","author":"Tolfvenstam","year":"2000","journal-title":"J Clin Virol"},{"key":"B74","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0889-857X(21)00895-4","article-title":"Fibromyalgia","volume":"16","author":"Wolfe","year":"1990","journal-title":"Rheum Dis Clin North Am"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01946\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T17:03:26Z","timestamp":1664125406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01946\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,14]]},"references-count":74,"alternative-id":["10.3389\/fimmu.2019.01946"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01946","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,14]]},"article-number":"1946"}}